EphA1 was significantly high in HER2-positive BC; EphA2 and EphA7 were significantly high in triple-negative BC, and EphA3, EphA5, EphA6, EphA8, and EphA10 were significantly high in luminal BC. Here, EPHA1 is linked to breast cancer.